Reviews for DITROPAN XL

2 ratings: (taken because of ocd)

 Edit Filter  |   Clear Filter  

Compare DITROPAN XL with similar:
 RELAXANTS STIMULANTS, URINARY TRACT

 Type: Rx Drug

  

DITROPAN XL  (OXYBUTYNIN CHLORIDE):  This is a long-acting form of oxybutynin that is used to treat overactive bladder and urinary conditions. It relaxes the muscles in the bladder to help decrease problems of urgency and frequent urination. Oxybutynin belongs to a class of drugs known as antispasmodics. This medication is also used to treat children 6 years of age and older who have an overactive bladder due to certain nerve disorders (e.g., spina bifida).   (Sources: U.S. Centers for Medicare Services, FDA) FDA Approval Date: 1999-06-22

  

Results are sorted by Date added.

Key to Ratings: 1=LOW (I would not recommend taking this medicine.)
5=HIGH (this medicine cured me or helped me a great deal.)

Page: 1


 

RATING  REASONSIDE EFFECTS FOR DITROPAN XLCOMMENTSSEXAGEDURATION/
DOSAGE
DATE ADDED
 
 5  Anxiety,OCD, Social anxiety,depress I haven't experience any side effect to date. Have tried about 20 psychriatric medications and suffered for 10 years. For the first time in my life I'm benzodiazepine free ssri free and my body gradually getting the balance it needs. no highs no downs just what my body needs. M 24 2 months
1/27/2010
Email
 1  Bathroom Anxiety/OCD None. I was prescribed this medication because my anxiety/OCD had me feeling like I had to urinate all of the time. After a month of use I concluded that Ditropan significantly intensified the feeling of having to urinate. M 23 1 months
8/30/2008
  

DITROPAN XL  (OXYBUTYNIN CHLORIDE):  This is a long-acting form of oxybutynin that is used to treat overactive bladder and urinary conditions. It relaxes the muscles in the bladder to help decrease problems of urgency and frequent urination. Oxybutynin belongs to a class of drugs known as antispasmodics. This medication is also used to treat children 6 years of age and older who have an overactive bladder due to certain nerve disorders (e.g., spina bifida).   (Sources: U.S. Centers for Medicare Services, FDA) FDA Approval Date: 1999-06-22

     

BACK TO TOP